Chemical Compound

Intermediate of Clarithromycin

CAS Registry Number 119665-62-2
Intermediate of Clarithromycin chemical structure
Primary Record

Intermediate of Clarithromycin

In stock
5,829 g
Purity
98.6 %
CAS
119665-62-2

Compound Identifiers & Properties

CAS
119665-62-2
PubChem CID
52915086
SMILES
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OC(C)(C)OCC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O[Si](C)(C)C)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O[Si](C)(C)C)(C)OC)C)C)O)(C)O
Canonical SMILES
CCOC(C)(C)O/N=C1\[C@H](C)C[C@@](C)(OC)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O[Si](C)(C)C)[C@@H](C)[C@H](O[C@H]2C[C@@](C)(OC)[C@@H](O[Si](C)(C)C)[C@H](C)O2)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@H]1C

Names & Synonyms

  • Intermediate of Clarithromycin
  • 119665-62-2
  • RefChem:401093
  • Erythromycin Impurity 11
  • Potassium dihydrogen phosphate
  • C49H96N2O14Si2
  • SCHEMBL29918373
  • MFCD09263749
  • AKOS015920282
  • DS-1405
  • BR-75808
  • 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime]-Erythromycin
  • ST24029836
  • O11621
  • S-1339
  • 665E622
  • A892485
  • Erythromycin, 6-O-methyl-2',4''-bis-O-(trimethylsilyl)-, 9-[O-(1-ethoxy-1-methylethyl)oxime]
  • Erythromycin Impurity 60; Clarithromycin Impurity 1
  • I14-16343
  • (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-trimethylsilyloxyoxan-2-yl]oxy-10-(2-ethoxypropan-2-yloxyimino)-14-ethyl-12,13-dihydroxy-7-methoxy-4-[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-trimethylsilyloxyoxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
  • 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)-9-[O-(1-ethoxy-1-methylethyl)oxime] Erythromycin
  • Erythromycin,6-O-methyl-2',4''-bis-O-(trimethylsilyl)-,9-[o-(1-ethoxy-1-methylethyl)oxime]
  • (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-[(trimethylsilyl)oxy]oxan-2-yl]oxy}-10-{[(2-ethoxypropan-2-yl)oxy]imino}-14-ethyl-12,13-dihydroxy-7-methoxy-4-{[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-[(trimethylsilyl)oxy]oxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one
  • 2',4"-O-bis(trimethylsilyl)-6-O-methylerythromycin A 9-[O-(1-ethoxy-1-methylethyloxime)]
  • 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)-9-O-(1-ethoxy-1-methylethyl)oxime Erythromycin
  • 6-O-Methyl-2',4''-bis-O-(trimethylsilyl)erythromycin- 9-[O-(1-ethoxy-1-methylethyl)oxime]
  • (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-((2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-trimethylsilyloxyoxan-2-yl)oxy-10-(2-ethoxypropan-2-yloxyimino)-14-ethyl-12,13-dihydroxy-7-methoxy-4-((2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-trimethylsilyloxyoxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
  • (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-trimethylsilyloxy-tetrahydropyran-2-yl]oxy-10-(1-ethoxy-1-methyl-ethoxy)imino-14-ethyl-12,13-dihydroxy-7-methoxy-4-[(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-trimethylsilyloxy-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
  • (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-6-methyl-3-((trimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-10-(((2-ethoxypropan-2-yl)oxy)imino)-14-ethyl-12,13-dihydroxy-7-methoxy-4-(((2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-((trimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecan-2-one
  • 1253181-39-3
  • 6-O-METHYL-2',4"-BIS-O-(TRIMETHYLSILYL)ERYTHROMYCIN 9-[O-(1-ETHOXY-1-METHYLETHYL)OXIME]
  • 6-O-METHYL-2,4-BIS-O-(TRIMETHYLSILYL)-9-[O-(1-ETHOXY-1-METHYLETHYL)OXIME]-ERYTHROMYCIN
  • 805-486-5
  • Erythromycin, 6-O-methyl-2',4''-bis-O-(trimethylsilyl)-, 9-(O-(1-ethoxy-1-methylethyl)oxime)
  • Erythromycin, 6-O-methyl-2',4''-bis-O-(trimethylsilyl)-, 9-[O-(1-ethoxy-1-methylethyl)oxime